MedPath

Effect of Fire Suppression and Emergency Duties on Vascular Function

Completed
Conditions
Atherothrombosis
Vascular Function
Interventions
Procedure: Forearm Vascular Study
Procedure: Badimon Chamber
Registration Number
NCT01805063
Lead Sponsor
University of Edinburgh
Brief Summary

Firefighters are at increased risk of death from heart attacks when compared to other emergencyy service professionals whose jobs involve similar components such as emergency call-outs and shift work. In the largest analysis of cause of death amongst on-duty firefighters, firefighter deaths were classified according to the duty performed during the onset of symptoms or immediately prior to any sudden death. The majority of deaths due to a cardiovascular cause (i.e. heart attack) occurred during fire suppression whilst this activity represented a relatively small amount of a firefighters professional time. There was also a risk of death associated with other duties such as emergency non-fire response and physical exertion.

The investigators hypothesize that participation in active fire-fighting duties impairs blood vessel function and increases blood clot formation when compared with non-fire-fighting activities. In this study, healthy career firefighters will be assessed after three periods of duty: fire-suppression, emergency response without fire suppression and following a sedentary shift. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess blood vessel function following these duties. By undertaking this comprehensive assessment of blood, blood vessel and heart function the investigators hope to understand the mechanisms whereby the risk of a heart attack, fatal or otherwise, is posed throughout these distinct duties that firefighters undertake on a daily basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Non-smoking healthy firefighters
Exclusion Criteria
  • Current smoker
  • History of lung or ischaemic heart disease
  • Malignant arrhythmia
  • Systolic blood pressure >190mmHg or <100mmHg
  • Renal or hepatic dysfunction
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Blood donation within the last 3 months
  • Recent respiratory tract infection within the past 4 weeks
  • Routine medication including aspirin and NSAIDs

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Fire suppressionBadimon ChamberFirefighters will attend for vascular assessments following a night shift where they have performed fire suppression
Non-fire emergency dutyBadimon ChamberFirefighters will attend for vascular assessments following a night shift where they have had an emergency response without fire suppression eg. road traffic collision.
Sedentary shiftBadimon ChamberFirefighters will attend for vascular assessments following a night shift where they have remained sedentary throughout the shift.
Fire suppressionForearm Vascular StudyFirefighters will attend for vascular assessments following a night shift where they have performed fire suppression
Non-fire emergency dutyForearm Vascular StudyFirefighters will attend for vascular assessments following a night shift where they have had an emergency response without fire suppression eg. road traffic collision.
Sedentary shiftForearm Vascular StudyFirefighters will attend for vascular assessments following a night shift where they have remained sedentary throughout the shift.
Primary Outcome Measures
NameTimeMethod
Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilatorsup to 12 hours after exposure
Secondary Outcome Measures
NameTimeMethod
Plasma t-PA and PAI concentrations following infusion of bradykininDuring forearm study, up to 12 hours after exposure
Ex-vivo thrombus formation using the Badimon chamberup to 12 hours after exposure

Trial Locations

Locations (1)

Royal Infirmary of Edinburgh Clinical Research Facility

🇬🇧

Edinburgh, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath